Neuropathic Pain: Challenges and Opportunities.
作者信息
van Velzen Monique, Dahan Albert, Niesters Marieke
机构信息
Department of Anesthesiology, Leiden University Medical Center, Leiden, Netherlands.
出版信息
Front Pain Res (Lausanne). 2020 Aug 7;1:1. doi: 10.3389/fpain.2020.00001. eCollection 2020.
Abstract
摘要
相似文献
1
Neuropathic Pain: Challenges and Opportunities.神经性疼痛：挑战与机遇
Front Pain Res (Lausanne). 2020 Aug 7;1:1. doi: 10.3389/fpain.2020.00001. eCollection 2020.
2
Pain following cancer treatment: Guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain.癌症治疗后的疼痛：主要神经性、伤害性和中枢敏化性疼痛的临床分类指南
Acta Oncol. 2016 Jun;55(6):659-63. doi: 10.3109/0284186X.2016.1167958. Epub 2016 May 4.
3
CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model.CXCL12/CXCR4 信号通过大鼠脊神经结扎模型中的中枢敏化机制促进神经性疼痛。
CNS Neurosci Ther. 2019 Sep;25(9):922-936. doi: 10.1111/cns.13128. Epub 2019 Apr 7.
4
Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain.腰痛：主要为神经性、伤害感受性或中枢敏化性疼痛的临床分类指南。
Pain Physician. 2015 May-Jun;18(3):E333-46.
5
Blockade of peripheral nociceptive signal input relieves the formation of spinal central sensitization and retains morphine efficacy in a neuropathic pain rat model.阻断外周伤害性信号传入可缓解脊髓中枢敏化的形成，并保留神经病理性疼痛大鼠模型中吗啡的疗效。
Neurosci Lett. 2020 Jan 18;716:134643. doi: 10.1016/j.neulet.2019.134643. Epub 2019 Nov 21.
6
Mechanisms and treatment of neuropathic pain.神经性疼痛的机制与治疗
Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):71-8. doi: 10.2174/187152409787601932.
7
8
Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats.杏仁核中央核团中神经元通过γ-氨基丁酸能抑制作用的降低而致敏，这有助于大鼠神经性疼痛相关焦虑样行为的发展。
Mol Brain. 2014 Oct 4;7:72. doi: 10.1186/s13041-014-0072-z.
9
[Neuropathic pain due to malignancy: mechanisms, clinical manifestations and therapy].[恶性肿瘤所致神经病理性疼痛：机制、临床表现及治疗]
Med Pregl. 2004 Jan-Feb;57(1-2):33-40. doi: 10.2298/mpns0402033p.
10
Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.外周神经病理性疼痛患者的局部治疗及其分子/细胞机制——叙述性综述
Pharmaceutics. 2021 Mar 26;13(4):450. doi: 10.3390/pharmaceutics13040450.
引用本文的文献
1
Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database.通过对FAERS数据库进行不成比例分析识别潜在的药物性神经痛信号。
Front Pharmacol. 2025 Jul 30;16:1645114. doi: 10.3389/fphar.2025.1645114. eCollection 2025.
2
Bibliometric Analysis: Insights Into the Podiatric Medicine Landscape of Diabetic Sensory Peripheral Neuropathy and Genomics.文献计量分析：洞察糖尿病感觉性周围神经病变与基因组学的足病医学领域
J Foot Ankle Res. 2025 Sep;18(3):e70062. doi: 10.1002/jfa2.70062.
3
Consensus Guidelines from the American Society of Pain and Neuroscience for the Use of 60-Day Peripheral Nerve Stimulation Therapy. A NEURON Living Guideline Project.美国疼痛与神经科学学会关于使用60天外周神经刺激疗法的共识指南。一个NEURON生活指南项目。
J Pain Res. 2025 Jun 24;18:3117-3139. doi: 10.2147/JPR.S521788. eCollection 2025.
4
A novel approach to completely alleviate peripheral neuropathic pain in human patients: insights from preclinical data.一种完全缓解人类患者周围神经病理性疼痛的新方法：来自临床前数据的见解。
Front Neuroanat. 2025 Jan 7;18:1523095. doi: 10.3389/fnana.2024.1523095. eCollection 2024.
5
Targeting the insular cortex for neuropathic pain modulation: Insights into synaptic and neuronal mechanisms.靶向岛叶皮质调节神经性疼痛：对突触和神经元机制的见解
FASEB J. 2025 Jan 31;39(2):e70285. doi: 10.1096/fj.202402381R.
6
Ethanolic Extracts of Linn. (Vitaceae) Attenuate Vincristine-Induced Peripheral Neuropathy in Rats: An Evidence of the Antioxidant, Calcium Inhibitory, and Neuromodulatory Properties.Linn.（葡萄科）的乙醇提取物减轻长春新碱诱导的大鼠周围神经病变：抗氧化、钙抑制和神经调节特性的证据
Adv Pharmacol Pharm Sci. 2024 Dec 12;2024:8822369. doi: 10.1155/adpp/8822369. eCollection 2024.
7
E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy.E-52862——一种选择性σ-1受体拮抗剂，用于治疗外周神经性疼痛：两项针对慢性术后疼痛和疼痛性糖尿病神经病变患者的随机、双盲2期研究。
Eur J Pain. 2025 Jan;29(1). doi: 10.1002/ejp.4755.
8
Gabapentinoids and Risk of Hip Fracture.加巴喷丁类药物与髋部骨折风险。
JAMA Netw Open. 2024 Nov 4;7(11):e2444488. doi: 10.1001/jamanetworkopen.2024.44488.
9
Upregulated spinal histone deacetylases induce nociceptive sensitization by inhibiting the GABA system in chronic constriction injury-induced neuropathy in rats.脊髓中上调的组蛋白去乙酰化酶通过抑制慢性缩窄性损伤诱导的大鼠神经病变中的γ-氨基丁酸（GABA）系统来诱导伤害性敏感化。
Pain Rep. 2024 Nov 6;9(6):e1209. doi: 10.1097/PR9.0000000000001209. eCollection 2024 Dec.
10
Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management.探讨 N-甲基-D-天冬氨酸受体拮抗剂在神经性疼痛管理中的治疗潜力。
Int J Mol Sci. 2024 Oct 16;25(20):11111. doi: 10.3390/ijms252011111.
本文引用的文献
1
Neuropathic Pain: Mechanism-Based Therapeutics.神经病理性疼痛：基于机制的治疗方法。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:257-274. doi: 10.1146/annurev-pharmtox-010818-021524.
2
Opioid utility function: methods and implications.阿片类药物效用函数：方法与启示
Ann Palliat Med. 2020 Mar;9(2):528-536. doi: 10.21037/apm.2019.10.09. Epub 2019 Nov 25.
3
Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature.关于 NMDA 受体拮抗剂氯胺酮治疗慢性神经性疼痛的药代动力学和药效学考虑因素：对最新文献的更新。
Expert Opin Drug Metab Toxicol. 2019 Dec;15(12):1033-1041. doi: 10.1080/17425255.2019.1689958. Epub 2019 Nov 13.
4
Nonnarcotic Methods of Pain Management.非麻醉性疼痛管理方法
N Engl J Med. 2019 Jun 20;380(25):2440-2448. doi: 10.1056/NEJMra1807061.
5
Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation.1 型糖尿病患者胰肾联合移植后早期神经纤维再生。
Diabetologia. 2019 Aug;62(8):1478-1487. doi: 10.1007/s00125-019-4897-y. Epub 2019 Jun 7.
6
Cornea nerve fibre state determines analgesic response to tapentadol in fibromyalgia patients without effective endogenous pain modulation.角膜神经纤维状态决定了曲马多在纤维肌痛患者中的镇痛反应，而这些患者没有有效的内源性疼痛调节。
Eur J Pain. 2019 Oct;23(9):1586-1595. doi: 10.1002/ejp.1435. Epub 2019 Jun 24.
7
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.一项关于药用大麻在纤维肌痛慢性疼痛患者中的镇痛效果的实验性随机研究。
Pain. 2019 Apr;160(4):860-869. doi: 10.1097/j.pain.0000000000001464.
8
A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication.描述阿片类药物和非阿片类镇痛药的风险-效益综合情况的实用效用函数。
J Pharmacol Exp Ther. 2019 Nov;371(2):416-421. doi: 10.1124/jpet.118.253716. Epub 2018 Nov 15.
9
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.美国 1979 年至 2016 年期间药物过量流行的动态变化。
Science. 2018 Sep 21;361(6408). doi: 10.1126/science.aau1184.
10
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016.成年人慢性疼痛和高影响慢性疼痛的患病率 - 美国，2016 年。
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006. doi: 10.15585/mmwr.mm6736a2.
Zotero 插件